6-64912570-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001142800.2(EYS):​c.2555T>C​(p.Leu852Pro) variant causes a missense change. The variant allele was found at a frequency of 0.593 in 1,550,694 control chromosomes in the GnomAD database, including 276,892 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L852A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.66 ( 34884 hom., cov: 32)
Exomes 𝑓: 0.59 ( 242008 hom. )

Consequence

EYS
NM_001142800.2 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 4.23

Publications

39 publications found
Variant links:
Genes affected
EYS (HGNC:21555): (eyes shut homolog) The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
EYS Gene-Disease associations (from GenCC):
  • EYS-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • retinitis pigmentosa 25
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.853312E-6).
BP6
Variant 6-64912570-A-G is Benign according to our data. Variant chr6-64912570-A-G is described in ClinVar as Benign. ClinVar VariationId is 93605.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.864 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EYSNM_001142800.2 linkc.2555T>C p.Leu852Pro missense_variant Exon 16 of 43 ENST00000503581.6 NP_001136272.1
EYSNM_001292009.2 linkc.2555T>C p.Leu852Pro missense_variant Exon 16 of 44 NP_001278938.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EYSENST00000503581.6 linkc.2555T>C p.Leu852Pro missense_variant Exon 16 of 43 5 NM_001142800.2 ENSP00000424243.1
EYSENST00000370621.7 linkc.2555T>C p.Leu852Pro missense_variant Exon 16 of 44 1 ENSP00000359655.3
ENSG00000308351ENST00000833459.1 linkn.173-3753A>G intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.664
AC:
100789
AN:
151842
Hom.:
34846
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.871
Gnomad AMI
AF:
0.557
Gnomad AMR
AF:
0.641
Gnomad ASJ
AF:
0.699
Gnomad EAS
AF:
0.408
Gnomad SAS
AF:
0.555
Gnomad FIN
AF:
0.577
Gnomad MID
AF:
0.630
Gnomad NFE
AF:
0.583
Gnomad OTH
AF:
0.654
GnomAD2 exomes
AF:
0.593
AC:
92797
AN:
156496
AF XY:
0.586
show subpopulations
Gnomad AFR exome
AF:
0.882
Gnomad AMR exome
AF:
0.619
Gnomad ASJ exome
AF:
0.695
Gnomad EAS exome
AF:
0.402
Gnomad FIN exome
AF:
0.580
Gnomad NFE exome
AF:
0.580
Gnomad OTH exome
AF:
0.612
GnomAD4 exome
AF:
0.585
AC:
818369
AN:
1398734
Hom.:
242008
Cov.:
42
AF XY:
0.583
AC XY:
402451
AN XY:
689884
show subpopulations
African (AFR)
AF:
0.887
AC:
28006
AN:
31578
American (AMR)
AF:
0.626
AC:
22335
AN:
35704
Ashkenazi Jewish (ASJ)
AF:
0.693
AC:
17452
AN:
25170
East Asian (EAS)
AF:
0.437
AC:
15592
AN:
35718
South Asian (SAS)
AF:
0.562
AC:
44528
AN:
79208
European-Finnish (FIN)
AF:
0.579
AC:
28540
AN:
49276
Middle Eastern (MID)
AF:
0.647
AC:
3689
AN:
5698
European-Non Finnish (NFE)
AF:
0.578
AC:
623169
AN:
1078404
Other (OTH)
AF:
0.605
AC:
35058
AN:
57978
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
18110
36220
54329
72439
90549
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17474
34948
52422
69896
87370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.664
AC:
100881
AN:
151960
Hom.:
34884
Cov.:
32
AF XY:
0.660
AC XY:
49037
AN XY:
74258
show subpopulations
African (AFR)
AF:
0.871
AC:
36149
AN:
41484
American (AMR)
AF:
0.641
AC:
9769
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.699
AC:
2426
AN:
3472
East Asian (EAS)
AF:
0.408
AC:
2107
AN:
5170
South Asian (SAS)
AF:
0.554
AC:
2665
AN:
4810
European-Finnish (FIN)
AF:
0.577
AC:
6094
AN:
10568
Middle Eastern (MID)
AF:
0.609
AC:
179
AN:
294
European-Non Finnish (NFE)
AF:
0.583
AC:
39600
AN:
67896
Other (OTH)
AF:
0.655
AC:
1384
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1616
3231
4847
6462
8078
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
788
1576
2364
3152
3940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.612
Hom.:
82135
Bravo
AF:
0.675
TwinsUK
AF:
0.586
AC:
2172
ALSPAC
AF:
0.568
AC:
2189
ESP6500AA
AF:
0.878
AC:
1215
ESP6500EA
AF:
0.575
AC:
1831
ExAC
AF:
0.595
AC:
14197
Asia WGS
AF:
0.556
AC:
1934
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Retinitis pigmentosa 25 Benign:5
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 04, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:3
Sep 19, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Apr 17, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 05, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The variant is found in ARRP panel(s).

Retinitis pigmentosa Benign:2
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.042
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
12
DANN
Benign
0.080
DEOGEN2
Benign
0.0
.;T
Eigen
Benign
-0.92
Eigen_PC
Benign
-0.72
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.14
T;T
MetaRNN
Benign
0.0000039
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.56
N;N
PhyloP100
4.2
PrimateAI
Benign
0.26
T
PROVEAN
Benign
4.3
N;N
REVEL
Benign
0.13
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Vest4
0.059
ClinPred
0.0061
T
GERP RS
3.1
Varity_R
0.047
gMVP
0.93
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9294631; hg19: chr6-65622463; COSMIC: COSV65505165; API